The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1974, 113: 764-768.
Copyright © 1974 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arroyave, C. M.
Right arrow Articles by Müller-Eberhard, H. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Arroyave, C. M.
Right arrow Articles by Müller-Eberhard, H. J.

Lysis of Human Erythrocytes Due to Activation of the Alternate Complement Pathway by Nephritic Factor (C3NeF)1,2,

Carlos M. Arroyave, Enrique H. Vallota and Hans J. Müller-Eberhard

From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037

Abstract

Nephritic factor (C3NeF) occurring in the serum of patients with hypocomplementemic chronic glomerulonephritis is known to activate complement via the alternate pathway. Addition of isolated C3NeF to normal serum resulted in assembly of the membrane attack mechanism of complement, the stable 22.5S C5b-9 complex.

In the presence of normal serum C3NeF caused lysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria or of glutathione-treated normal human erythrocytes. The extent of cell lysis was proportional to the amount of C3NeF employed. Sera from patients with hypocomplementemic chronic nephritis containing C3NeF were shown to be hemolytically inactive because of lack of C3. Cell lysis induced by C3NeF ensued upon addition of isolated C3 to nephritic sera. The results show that C3NeF is capable of initiating cell injury through activation of the alternate pathway, and that the impairment of this pathway in C3NeF-containing sera is due to C3 deficiency. Lysis of glutathione-treated erythrocytes initiated by C3NeF may be used as an alternative assay for C3NeF.

Footnotes

1 This is publication number 805 from the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037.

2 This work was supported by United States Public Health Service Grant AI-07007.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1974 by The American Association of Immunologists, Inc. All rights reserved.